Prospect Medical Holdings Joins Russell Microcap Index
July 01 2009 - 2:00PM
Business Wire
Prospect Medical Holdings, Inc. (NYSE Amex: PZZ)
(�Prospect�), which owns and operates five hospitals and manages
the medical care of HMO enrollees in Southern California, today
announced that it has joined the Russell Microcap� Index.
Prospect�s inclusion became effective upon the close of trading on
Friday, June 26, 2009 following the Russell Investment Group�s
annual reconstitution of these lists.
Sam Lee, Chairman and Chief Executive Officer of Prospect,
commented, �Prospect�s inclusion on the Russell Microcap Index is
an important corporate milestone. This ranking reflects the hard
work, perseverance and dedication of our talented group of
professionals, and evidences our continued organizational
development and progress. We expect that being part of the Russell
Microcap Index will elevate our profile among those investors who
utilize the Russell indexes in making their investment
decisions.�
Russell indexes are widely used by investment managers and
institutional investors for index funds and as benchmarks for both
passive and active investment strategies. An industry-leading $4
trillion in assets currently are benchmarked to them. These
investment tools originated from Russell�s multi-manager investment
business in the early 1980s when the company saw the need for a
more objective, market-driven set of benchmarks in order to
evaluate outside investment managers. Total returns data for the
Russell Microcap and other Russell Indexes is available at
http://www.russell.com/Indexes/performance/default.asp.
ABOUT PROSPECT MEDICAL
HOLDINGS
Prospect Medical Holdings operates five hospitals in the greater
Los Angeles area and manages the medical care of approximately
183,000 individuals enrolled in HMO plans in Southern California,
through a network of approximately 14,000 specialist and primary
care physicians.
This press release contains forward-looking statements.
Additional written or oral forward-looking statements may be made
by Prospect from time to time, in filings with the Securities and
Exchange Commission, or otherwise. Statements contained herein that
are not historical facts are forward-looking statements. Investors
are cautioned that forward-looking statements, including the
statements regarding anticipated or expected results, involve risks
and uncertainties which may affect the Company's business and
prospects, including those outlined in Prospect's Form 10-K filed
on December 29, 2008, as well as risks and uncertainties arising
from Prospect's acquisition of Alta and ProMed, and the debt
incurred by Prospect in connection with those acquisitions. Any
forward-looking statements contained in this press release
represent our estimates only as of the date hereof, or as of such
earlier dates as are indicated, and should not be relied upon as
representing our estimates as of any subsequent date. While we may
elect to update forward-looking statements at some point in the
future, we specifically disclaim any obligation to do so, even if
our estimates change.
Prospect Medical (AMEX:PZZ)
Historical Stock Chart
From Oct 2024 to Nov 2024
Prospect Medical (AMEX:PZZ)
Historical Stock Chart
From Nov 2023 to Nov 2024